Effects of Liraglutide as Add-on to Metformin on Hepatic Steatosis and Fibrosis in Patients with Prediabetes and MASLD: A Retrospective Cohort Study
Journal of Gastrointestinal and Liver Diseases · 21.11.2026
DOI: 10.15403/jgld-6926 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Gastrointestinal and Liver Diseases, online erschienen am 21.11.2026. Verfasst von Qin He und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background and Aims: The coexistence of prediabetes and metabolic dysfunction-associated steatotic liver disease (MASLD) is common and accelerates metabolic and hepatic complications. This study evaluated the effects of liraglutide on hepatic steatosis and fibrosis in patients with prediabetes and MASLD.
Methods
This retrospective cohort study included 263 patients with prediabetes and MASLD who received either liraglutide plus metformin (liraglutide group, n=142) or metformin alone (control group, n=121) for 12 months. Primary outcomes were changes in controlled attenuation parameter (CAP), liver stiffness measurement (LSM), Fibrosis-4 (FIB-4) index, and non-alcoholic fatty liver disease fibrosis score (NFS). Secondary outcomes included anthropometric measurements, glycemic parameters, lipid profiles, and liver enzymes.
Results
After 12 months of treatment, CAP values decreased significantly in both groups (both p
Zitieren
APA
He, Q., Yang, J., Tang, R., & Wang, W. (2026). Effects of Liraglutide as Add-on to Metformin on Hepatic Steatosis and Fibrosis in Patients with Prediabetes and MASLD: A Retrospective Cohort Study. Journal of Gastrointestinal and Liver Diseases. https://doi.org/10.15403/jgld-6926
Vancouver
He Q, Yang J, Tang R, Wang W. Effects of Liraglutide as Add-on to Metformin on Hepatic Steatosis and Fibrosis in Patients with Prediabetes and MASLD: A Retrospective Cohort Study. Journal of Gastrointestinal and Liver Diseases. 2026. doi:10.15403/jgld-6926
BibTeX
@article{He2026,
author = {He, Qin and Yang, Jianming and Tang, Renmin and Wang, Wen},
title = {Effects of Liraglutide as Add-on to Metformin on Hepatic Steatosis and Fibrosis in Patients with Prediabetes and MASLD: A Retrospective Cohort Study},
journal = {Journal of Gastrointestinal and Liver Diseases},
year = {2026},
doi = {10.15403/jgld-6926}
}
EUVIMED